| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.2M | +20.2% | +90.1% |
| R&D Expense | $6.5M | -12.8% | -52.6% |
| SG&A Expense | $3.3M | -5.1% | -12.2% |
| Operating Income | -$7.7M | +16.4% | +53.2% |
| Net Income | -$7.1M | +16.6% | +52.9% |
| EPS (Basic) | -$3.72 | +16.6% | -830.0% |
| EPS (Diluted) | -$3.72 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.8M | +84.9% | +89.5% |
| Short-term Investments | $14.2M | -43.8% | -68.1% |
| Current Assets | $35.6M | -7.1% | -37.7% |
| Total Assets | $65.1M | -13.8% | -40.5% |
| Current Liabilities | $10.0M | -19.0% | -44.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$32.7M | — | — |
| Capital Expenditures | $72K | — | — |
| Investing Cash Flow | $43.2M | — | — |
| Financing Cash Flow | $14K | — | — |
| Free Cash Flow | -$32.8M | — | — |
| +16.6% |
| -830.0% |
| $33.0M |
| -10.1% |
| -11.7% |
| Stockholders' Equity | $32.1M | -17.4% | -55.4% |